Business Context and Reporting Period
This Form 8-K, dated July 26, 2024, reports on a material definitive agreement entered into by Firefly Neuroscience, Inc. (the "Company") in connection with its pending merger with WaveDancer, Inc. (the "Parent"). The filing details a private placement transaction intended to close substantially contemporaneously with the consummation of the Merger.
Key Financial Metrics and Transaction Details
- Transaction Type: Private placement of common stock, pre-funded warrants, and warrants.
- Securities Issued: 7,918,552.03 shares of Common Stock (or Pre-Funded Warrants to avoid exceeding beneficial ownership limits) and Warrants to purchase an equal number of shares.
- Purchase Price: $0.442 per Share and accompanying Warrant; $0.4419 per Pre-Funded Warrant.
- Aggregate Gross Proceeds: Approximately $3.5 million.
- Warrant Terms: Exercise price of $0.71 per share; exercisable immediately; expire five years from issuance.
- Pre-Funded Warrant Terms: Exercise price of $0.0001 per share; exercisable immediately; subject to beneficial ownership limitations (4.99% or 9.99% of Parent common stock).
Material Changes and Pro Forma Information
The filing does not provide historical revenue, profit, or cash flow metrics for the Company. Instead, it references unaudited pro forma condensed combined financial statements for the year ended December 31, 2023, and the three months ended March 31, 2024, which give effect to the Merger and the Private Placement. These statements are filed as Exhibit 99.1 and are not detailed within the text of this summary.
Outlook, Risks, and Contingencies
- Closing Conditions: The Private Placement is subject to the satisfaction of customary closing conditions and the consummation of the Merger.
- Ownership Caps: Issuance of Pre-Funded Warrants is contingent on preventing the investor from beneficially owning more than 4.99% (or 9.99% at election) of the Parent's outstanding common stock immediately following the Merger.
- Registration Status: Securities are issued under Section 4(a)(2) and Regulation D exemptions; they are not registered under the Securities Act of 1933.
- Adjustments: The number of securities and exercise prices are subject to adjustment based on the Exchange Ratio applied in the Merger.
Investor Verification Checklist
- Verify the final Exchange Ratio applied to the Company's outstanding shares in the Merger, as this adjusts the number of securities issued.
- Review Exhibit 99.1 for the unaudited pro forma financial statements to understand the combined entity's financial position.
- Confirm the specific beneficial ownership percentage election (4.99% vs. 9.99%) made by the institutional investor.
- Examine the full Securities Purchase Agreement (Exhibit 10.1) for termination provisions and specific closing conditions.